Valuation: Baxter International Inc.

Capitalization 949.98Cr 816.6Cr 764.98Cr 713.01Cr 1.32TCr 85TCr 1.43TCr 8.95TCr 3.45TCr 40TCr 3.57TCr 3.49TCr 1,47600Cr P/E ratio 2025 *
73.9x
P/E ratio 2026 * 21.1x
Enterprise value 1.68TCr 1.44TCr 1.35TCr 1.26TCr 2.33TCr 1,51100Cr 2.53TCr 16TCr 6.11TCr 71TCr 6.3TCr 6.17TCr 2,60900Cr EV / Sales 2025 *
1.52x
EV / Sales 2026 * 1.36x
Free-Float
74.36%
Yield 2025 *
3.73%
Yield 2026 * 0.79%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.51%
1 week-0.67%
Current month-0.67%
1 month+3.70%
3 months-23.77%
6 months-38.26%
Current year-36.16%
More quotes
1 week 18.33
Extreme 18.33
19.2
1 month 17.4
Extreme 17.4
19.2
Current year 17.4
Extreme 17.4
37.74
1 year 17.4
Extreme 17.4
37.74
3 years 17.4
Extreme 17.4
53.8
5 years 17.4
Extreme 17.4
89.7
10 years 17.4
Extreme 17.4
95.19
More quotes
Manager TitleAgeSince
Chief Executive Officer 48 01/08/2025
Director of Finance/CFO 55 18/10/2023
Chief Tech/Sci/R&D Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 74 06/02/2017
Director/Board Member 61 18/07/2017
Director/Board Member 65 18/02/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.51%-0.67%-41.65%-63.71% 949.98Cr
-0.45%-2.96%+8.21%+18.67% 22TCr
-0.60%-3.64%+20.63%+28.82% 13TCr
+0.34%-7.73%+39.34%+98.75% 6.55TCr
+0.24%+0.11%-12.60%-21.11% 5.53TCr
+0.25%+2.09%+20.19%+70.41% 5.21TCr
+0.94%-1.11%+21.11%+41.98% 2.56TCr
+0.67%+3.80%-16.52%-43.48% 2.54TCr
-0.33%+5.07%+17.94%-37.25% 2.43TCr
-2.23%-2.27%-23.56%+17.98% 2.31TCr
Average -0.05%-0.67%+3.31%+11.11% 6.3TCr
Weighted average by Cap. -0.21%-1.91%+11.18%+24.91%
See all sector performances

Financials

2025 *2026 *
Net sales 1.11TCr 952.36Cr 892.15Cr 831.55Cr 1.54TCr 1LCr 1.67TCr 10TCr 4.03TCr 47TCr 4.16TCr 4.07TCr 1,72200Cr 1.13TCr 973.7Cr 912.14Cr 850.18Cr 1.57TCr 1,01900Cr 1.71TCr 11TCr 4.12TCr 48TCr 4.25TCr 4.16TCr 1,76000Cr
Net income -4.3Cr -3.7Cr -3.46Cr -3.23Cr -5.96Cr -386.99Cr -6.48Cr -41Cr -16Cr -182.77Cr -16Cr -16Cr -668.29Cr 32Cr 27Cr 26Cr 24Cr 44Cr 2.88TCr 48Cr 301.27Cr 116.33Cr 1.36TCr 120.05Cr 117.49Cr 4.97TCr
Net Debt 729.03Cr 626.68Cr 587.06Cr 547.18Cr 1.01TCr 66TCr 1.1TCr 6.87TCr 2.65TCr 31TCr 2.74TCr 2.68TCr 1,13300Cr 590.56Cr 507.65Cr 475.56Cr 443.25Cr 818.71Cr 53TCr 890.51Cr 5.56TCr 2.15TCr 25TCr 2.22TCr 2.17TCr 92TCr
More financial data * Estimated data
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (49%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.7%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.7%): injectable medications, inhaled anesthetics, and drug compounding services; - other (0.6%). The United States account for 55% of net sales.
Employees
38,000
More about the company
Date Price Change Volume
06/25/06 18.62 $ +0.78% 59,62,435
04/25/04 18.48 $ -2.17% 79,34,062
03/25/03 18.89 $ +0.27% 60,94,340
02/25/02 18.84 $ -1.26% 84,57,549
01/25/01 19.08 $ +1.81% 96,35,110

Delayed Quote Nyse, December 06, 2025 at 02:02 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
18.48USD
Average target price
23.80USD
Spread / Average Target
+28.79%
Consensus

Quarterly revenue - Rate of surprise